AeroClave Logo.png
AeroClave Onboards New Channel Partner, Hunter Apparatus
20 févr. 2024 09h03 HE | AeroClave
WINTER PARK, Fla., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Leading decontamination technology provider, AeroClave today announces its lucrative channel partnership with Hunter Apparatus, an authorized...
image (5).png
Qure.ai adds new FDA breakthrough device status to growing list of regulatory milestones
05 févr. 2024 09h00 HE | Qure.ai Technologies Private Limited
NEW YORK, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Medical imaging AI innovator, Qure.ai, has received breakthrough device designation from the Food and Drug Administration's (FDA) Center for Devices and...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Wearable Sensors Market Expected to Reach USD 10.19 Billion by 2033 | Impressive CAGR of 12.8%
29 janv. 2024 03h51 HE | Market.Us
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- According to Market.us, The Wearable Sensors market size is expected to be worth around USD 10.19 Billion by 2033 from USD 3.55 Billion in 2023, growing...
AeroClave Logo.png
AeroClave Offers New Funding Path for Industrial Decontamination Solution With GovFunds
23 janv. 2024 09h00 HE | AeroClave
WINTER PARK, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- AeroClave, a leading provider in decontamination technology, today announces its partnership with GovFunds to provide prospective customers...
website-logo (2).png
Cell Therapy Technologies Market Projected to Reach Valuation of USD 47.3 Billion at 24.7% CAGR from 2024-2033 | Marketresearch.biz Study
16 janv. 2024 02h33 HE | MarketResearch.biz
New York, Jan. 16, 2024 (GLOBE NEWSWIRE) -- In 2023 Cell therapy technologies market were valued at USD 5.5 billion in 2023 with significant growth and are projected to reach USD 47.3 billion by...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Personal Health Record Software Market to Exceed USD 21.7 Billion by 2033; Amid Rising Popularity of Digital Health Solutions and Patient-Centric Healthcare
08 janv. 2024 07h31 HE | Market.Us
New York, Jan. 08, 2024 (GLOBE NEWSWIRE) -- According to market.us, the Personal Health Record Software Market is expected to achieve a valuation of approximately USD 21.7 Billion by 2033,...
logo.png
Nexstim receives Nexstim NBS System 5 order from Distributor in Europe
29 déc. 2023 03h00 HE | Nexstim Oyj
Press release, Helsinki, 29 December 2023 at 10 AM (EEST) Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a distributor company based in Europe. ...
akido_logo (1).png
Rhode Island Primary Care Physicians Corporation Announces Joint Venture with Akido Labs
21 déc. 2023 10h05 HE | Akido Labs
This Joint Venture is Marked by the Creation of Bicoastal Health Care Innovation Hubs Designed to Develop Best Practices in Care
Replay_Logo_Black_CMYK.png
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy®
18 déc. 2023 07h00 HE | Replay Bio
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy® Syena...
Replay_Logo_Black_CMYK.png
Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens
18 déc. 2023 07h00 HE | Replay Bio
Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens Replay and its...